1. Study presented at AAIC 2025.
2. Involves 270 breast cancer patients post-chemotherapy.
3. Significant grey matter volume loss noted in specific brain regions.
4. Cognitive deficits linked to memory and executive functions.
5. Chemotherapy may cause neuroinflammation and vascular toxicity.
6. 'Chemobrain' affects approximately 33% of survivors.
7. Potential for persistent cognitive symptoms.
8. Findings may improve early detection of cognitive impairments.

Source: AAIC 2025